A team from Takeda Pharmaceutical has developed a new model for monitoring bioreactors that could speed up process development. The scientists used Lonza’s Modular Automated Sampling Technology (MAST) ...
Bioprocess monitoring and control, although not as widespread as it should be, is nevertheless increasingly viewed as a routine part of doing business. Significant trends include interconnectivity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results